Literature DB >> 18566416

Dynamic protein associations define two phases of IL-1beta transcriptional activation.

Yue Zhang1, Simona Saccani, Hyunjin Shin, Barbara S Nikolajczyk.   

Abstract

IL-1beta is a key proinflammatory cytokine with roles in multiple diseases. Monocytes package the IL-1beta promoter into a "poised architecture" characterized by a histone-free transcription start site and constitutive transcription factor associations. Upon LPS stimulation, multiple proteins inducibly associate with the IL-1beta gene. To understand how the complex combination of constitutive and inducible transcription factors activate the IL-1beta gene from a poised structure, we measured temporal changes in NF-kappaB and IFN regulatory factor (IRF) association with IL-1beta regulatory elements. Association of the p65 subunit of NF-kappaB peaks 30-60 min post-monocyte stimulation, and it shortly precedes IRF-4 recruitment to the IL-1beta enhancer and maximal mRNA production. In contrast, IRF-8/enhancer association decreases poststimulation. To test the importance of delayed IRF-4/enhancer association, we introduced a mutated PU.1 protein shown to prevent PU.1-mediated IRF-4 recruitment to the enhancer sequence. Mutated PU.1 initially increased IL-1beta mRNA followed by decreased mRNA levels 2-3 h poststimulation. Taken together, these data support a dynamic model of IL-1beta transcriptional activation in which a combination of IRF-8 and p65 drives the initial phase of IL-1beta transcription, while PU.1-mediated IRF-4 recruitment to the enhancer is important for the second phase. We further demonstrate that activation of both NF-kappaB and IRF-4 depends on CK2 kinase activity. Because IRF-4/enhancer association requires CK2 but not p65 activation, we conclude that CK2 triggers the IRF-4 and p65 pathways independently to serve as a master regulator of IL-1beta transcription.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566416      PMCID: PMC2967210          DOI: 10.4049/jimmunol.181.1.503

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

1.  Cutting edge: chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific cytokine gene cluster.

Authors:  N Takemoto; Y Kamogawa; H Jun Lee; H Kurata; K I Arai; A O'Garra; N Arai; S Miyatake
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

2.  During ontogeny primitive (CD34(+)CD38(-)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts.

Authors:  I H Oh; A Lau; C J Eaves
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

3.  Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter.

Authors:  T Agalioti; S Lomvardas; B Parekh; J Yie; T Maniatis; D Thanos
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

4.  Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci.

Authors:  M D Litt; M Simpson; F Recillas-Targa; M N Prioleau; G Felsenfeld
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

5.  PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene.

Authors:  S Marecki; C J Riendeau; M D Liang; M J Fenton
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

6.  Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response.

Authors:  Vladimir R Ramirez-Carrozzi; Aaron A Nazarian; Caiyi C Li; Sarah L Gore; Rupa Sridharan; Anthony N Imbalzano; Stephen T Smale
Journal:  Genes Dev       Date:  2006-02-01       Impact factor: 11.361

7.  Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.

Authors:  R Romieu-Mourez; E Landesman-Bollag; D C Seldin; A M Traish; F Mercurio; G E Sonenshein
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

8.  Regulation of IL-12 p40 promoter activity in primary human monocytes: roles of NF-kappaB, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E(2).

Authors:  C Becker; S Wirtz; X Ma; M Blessing; P R Galle; M F Neurath
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

9.  Protein kinase CK2 in mammary gland tumorigenesis.

Authors:  E Landesman-Bollag; R Romieu-Mourez; D H Song; G E Sonenshein; R D Cardiff; D C Seldin
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

10.  Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene.

Authors:  J Tsukada; K Saito; W R Waterman; A C Webb; P E Auron
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

View more
  25 in total

Review 1.  Targeting innate immunity protein kinase signalling in inflammation.

Authors:  Matthias Gaestel; Alexey Kotlyarov; Michael Kracht
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

2.  Protein Kinase CK2: An Emerging Regulator of Immunity.

Authors:  Sara A Gibson; Etty N Benveniste
Journal:  Trends Immunol       Date:  2018-01-04       Impact factor: 16.687

3.  Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma.

Authors:  Marrah E Lachowicz-Scroggins; Eleanor M Dunican; Annabelle R Charbit; Wilfred Raymond; Mark R Looney; Michael C Peters; Erin D Gordon; Prescott G Woodruff; Emma Lefrançais; Brenda R Phillips; David T Mauger; Suzy A Comhair; Serpil C Erzurum; Mats W Johansson; Nizar N Jarjour; Andrea M Coverstone; Mario Castro; Annette T Hastie; Eugene R Bleecker; Merritt L Fajt; Sally E Wenzel; Elliot Israel; Bruce D Levy; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

4.  p38γ and p38δ kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation.

Authors:  Ana Risco; Carlos del Fresno; Agnes Mambol; Dayanira Alsina-Beauchamp; Kirsty F MacKenzie; Huei-Ting Yang; Domingo F Barber; Carmen Morcelle; J Simon C Arthur; Steven C Ley; Carlos Ardavin; Ana Cuenda
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

5.  Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis.

Authors:  Inga Wessels; Daniela Fleischer; Lothar Rink; Peter Uciechowski
Journal:  Immunology       Date:  2010-02-05       Impact factor: 7.397

6.  Tick Salivary Sialostatin L Represses the Initiation of Immune Responses by Targeting IRF4-Dependent Transcription in Murine Mast Cells.

Authors:  Matthias Klein; Till-Julius Brühl; Valérie Staudt; Sebastian Reuter; Nadine Grebe; Bastian Gerlitzki; Markus Hoffmann; Toszka Bohn; Alexander Ulges; Natascha Stergiou; Jos de Graaf; Martin Löwer; Christian Taube; Marc Becker; Tobias Hain; Sarah Dietzen; Michael Stassen; Magdalena Huber; Michael Lohoff; Andrezza Campos Chagas; John Andersen; Jan Kotál; Helena Langhansová; Jan Kopecký; Hansjörg Schild; Michalis Kotsyfakis; Edgar Schmitt; Tobias Bopp
Journal:  J Immunol       Date:  2015-06-15       Impact factor: 5.422

7.  TSC1 controls IL-1β expression in macrophages via mTORC1-dependent C/EBPβ pathway.

Authors:  Tao Yang; Linnan Zhu; Yanhua Zhai; Qingjie Zhao; Jianxia Peng; Hongbing Zhang; Zhongzhou Yang; Lianfeng Zhang; Wenjun Ding; Yong Zhao
Journal:  Cell Mol Immunol       Date:  2015-05-25       Impact factor: 11.530

8.  Bone morphogenetic protein signaling in vascular disease: anti-inflammatory action through myocardin-related transcription factor A.

Authors:  Dahai Wang; Jamunabai Prakash; Peter Nguyen; Brandi N Davis-Dusenbery; Nicholas S Hill; Matthew D Layne; Akiko Hata; Giorgio Lagna
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

9.  Computational design and application of endogenous promoters for transcriptionally targeted gene therapy for rheumatoid arthritis.

Authors:  Jeroen Geurts; Leo A B Joosten; Nozomi Takahashi; Onno J Arntz; Anton Glück; Miranda B Bennink; Wim B van den Berg; Fons A J van de Loo
Journal:  Mol Ther       Date:  2009-08-18       Impact factor: 11.454

10.  DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes.

Authors:  Ko Hashimoto; Richard O C Oreffo; Marc B Gibson; Mary B Goldring; Helmtrud I Roach
Journal:  Arthritis Rheum       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.